Cereboost (Panax quinquefolius)

Cereboost is a standardized American ginseng (Panax quinquefolius) extract containing a specific profile of ginsenosides, particularly Rb1, Rc, and Re, which modulate neurotransmitter activity and acetylcholinesterase inhibition to support cognitive function. It demonstrates acute, dose-dependent improvements in working memory, attention, and mood within hours of a single dose in healthy adults.

Origin & History

Cereboost is a branded extract derived from the roots of Panax quinquefolius L. (American ginseng), a perennial plant native to North America. Produced by Naturex (now part of Givaudan) through a proprietary extraction process, it is standardized to contain 10-12% total ginsenosides, which are triterpenoid saponins responsible for its bioactive properties.

Historical & Cultural Context

American ginseng (Panax quinquefolius) has been traditionally used in both Native American and traditional Chinese medicine for vitality, stress adaptation, and cognitive support. Modern standardized extracts like Cereboost build upon this traditional foundation to target specific neurocognitive benefits.

Health Benefits

• Enhanced short-term memory - demonstrated in randomized controlled trial (n=42) with significant improvements 2-6 hours post-dose
• Improved attention and alertness - clinical evidence shows acute cognitive benefits in healthy adults
• Mood support - peer-reviewed trials document mood benefits at 200mg/day dose
• Energy enhancement - clinically studied for energy improvements in healthy populations
• Stress adaptation - traditional adaptogenic properties through ginsenoside modulation of neurocognitive pathways

How It Works

Cereboost ginsenosides, primarily Rb1 and Re, inhibit acetylcholinesterase activity, thereby increasing synaptic acetylcholine availability in the prefrontal cortex and hippocampus to enhance working memory and attention. Ginsenoside Re also modulates NMDA receptor activity and dopaminergic signaling pathways, contributing to improved alertness and mood stabilization. Additionally, these ginsenosides exhibit antioxidant activity by upregulating Nrf2-mediated pathways, reducing oxidative stress in neural tissue that can impair cognitive performance.

Scientific Research

A randomized, placebo-controlled, double-blind trial (n=42 healthy adults) showed that 200mg of Cereboost standardized to 10-12% ginsenosides significantly improved short-term memory and attention/alertness, with cognitive benefits observed 2-6 hours post-dose. An ongoing RCT (NCT07255755, REACT study) is evaluating acute cognitive effects of 200mg in healthy young adults using cognitive tests and blood samples over 6 hours.

Clinical Summary

A randomized, double-blind, placebo-controlled crossover trial (n=42 healthy adults) demonstrated statistically significant improvements in working memory and attention using the Cognitex battery at 1, 3, and 6 hours post-dose with 200mg and 400mg Cereboost. The 400mg dose produced the most consistent improvements across multiple cognitive domains including spatial working memory and choice reaction time. A separate peer-reviewed trial documented acute mood benefits at 200mg, including reduced mental fatigue scores. Evidence is currently limited to acute, single-dose studies in healthy populations, and long-term or therapeutic efficacy data remain insufficient.

Nutritional Profile

Cereboost is a standardized extract of American ginseng (Panax quinquefolius), not consumed as a whole food but as a concentrated phytochemical supplement. Key bioactive compounds include ginsenosides (also called panaxosides), with the extract standardized to contain approximately 10-12% total ginsenosides by weight. Primary ginsenosides present include Rb1, Rb2, Rc, Rd, Re, and Rg1, with the Rb-group (protopanaxadiol-type) typically predominating over Rg-group (protopanaxatriol-type) in American ginseng, distinguishing it from Asian ginseng (Panax ginseng). Typical clinical dosing is 100-400 mg of the standardized extract per day, delivering roughly 10-48 mg of total ginsenosides per dose. The extract also contains polysaccharides (notably quinquefolans and ginsenans, ~5-10% of crude extract), which may contribute to immunomodulatory activity, as well as polyacetylenes (e.g., panaxynol, panaxydol) in trace amounts. Minor constituents include flavonoids, phenolic acids, and peptides. The extract is negligible in macronutrients (protein, fat, carbohydrate, fiber) at supplemental doses. No significant vitamin or mineral content is attributed to the extract itself. Bioavailability of ginsenosides is relatively low when taken orally (~1-5% for major ginsenosides like Rb1); however, gut microbiota metabolize them into more bioactive compounds such as compound K (from protopanaxadiol-type ginsenosides) and protopanaxatriol (from Rg1/Re), which are more readily absorbed. Taking the extract with food may modestly improve absorption. The Cereboost extract is produced via proprietary aqueous-ethanolic extraction processes to enrich ginsenoside content and ensure batch-to-batch consistency.

Preparation & Dosage

Clinically studied dose: 200mg of Cereboost extract (standardized to 10-12% total ginsenosides) taken as encapsulated extract for acute cognitive effects. Studies have focused on single-dose administration with benefits observed 2-6 hours post-ingestion. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bacopa monnieri, Lion's Mane, L-theanine, Rhodiola rosea, Phosphatidylserine

Safety & Interactions

Cereboost is generally well tolerated at studied doses of 200–400mg, with no serious adverse events reported in clinical trials; mild gastrointestinal discomfort is the most commonly noted side effect. Because American ginseng can modestly lower blood glucose, individuals taking antidiabetic medications such as metformin or insulin should monitor glycemic levels closely and consult a physician. Panax quinquefolius may interact with warfarin by altering its pharmacokinetics, potentially reducing anticoagulant efficacy, making concurrent use inadvisable without medical supervision. Pregnant or breastfeeding women should avoid use due to insufficient safety data, and individuals with hormone-sensitive conditions should exercise caution given the mild estrogenic activity of certain ginsenosides.